A new NPY-antagonist strongly stimulates apoptosis and lipolysis on white adipocytes in an obesity model

  • Javier Margareto
  • , Miriam Aguado
  • , Juan A. Osés-Prieto
  • , Isabel Rivero
  • , Antonio Monge
  • , Ignacio Aldana
  • , Amelia Marti
  • , J. Alfredo Martínez*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)

Abstract

Neuropeptide Y (NPY) is a 36 amino acid peptide released in central and peripheral mammalian neurons, which appears to contribute to adiposity regulation by increasing food intake, thus promoting weight gain on animals. Nevertheless, little is known about NPY direct actions on white adipocytes. This trial, which was designed to test the possible effects of a new NPY antagonist, S.A.0204, on white adipose tissue, revealed that the administration of this novel molecule strongly ex vivo stimulates apoptosis and lipolysis in animals fed on a high-fat diet. (C) 2000 Elsevier Science Inc.

Original languageEnglish
Pages (from-to)99-107
Number of pages9
JournalLife Sciences
Volume68
Issue number1
DOIs
Publication statusPublished - 24 Nov 2000
Externally publishedYes

Keywords

  • Apoptosis
  • High-fat diets
  • Lipolysis
  • NPY-antagonist
  • Obesity
  • White Adipose Tissue

Fingerprint

Dive into the research topics of 'A new NPY-antagonist strongly stimulates apoptosis and lipolysis on white adipocytes in an obesity model'. Together they form a unique fingerprint.

Cite this